title: HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.
abstract: Human immunodeficiency virus type 1 (HIV) infection presently affects more that 40 million people worldwide, and is associated with central nervous system (CNS) disruption in at least 30% of infected individuals. The use of highly active antiretroviral therapy has lessened the incidence, but not the prevalence of mild impairment of higher cognitive and cortical functions (HIV-associated neurocognitive disorders) as well as substantially reduced a more severe form dementia (HIV-associated dementia). Furthermore, improving neurological outcomes will require novel, adjunctive therapies that are targeted towards mechanisms of HIV-induced neurodegeneration. Identifying such molecular and pharmacological targets requires an understanding of the events preceding irreversible neuronal damage in the CNS, such as actions of neurotoxins (HIV proteins and cellular factors), disruption of ion channel properties, synaptic damage, and loss of adult neurogenesis. By considering the specific mechanisms and consequences of HIV neuropathogenesis, unified approaches for neuroprotection will likely emerge using a tailored, combined, and non-invasive approach.
authors.affiliation: Department of Pathology, School of Dental Medicine, University of Pennsylvania, 240 S. 40th St, Room 312 Levy Building, Philadelphia, PA 19104-6030, USA.
authors.forename: Kathryn A
authors.initials: KA
authors.lastname: Lindl
authors.forename: David R
authors.initials: DR
authors.lastname: Marks
authors.forename: Dennis L
authors.initials: DL
authors.lastname: Kolson
authors.forename: Kelly L
authors.initials: KL
authors.lastname: Jordan-Sciutto
mesh_terms: D015526:AIDS Dementia Complex / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D000818:Animals; D019380:Anti-HIV Agents / Q000627:therapeutic use; D001921:Brain / Q000821:virology; D015497:HIV-1 / Q000502:physiology; D006801:Humans; D008559:Memantine / Q000627:therapeutic use; D008911:Minocycline / Q000627:therapeutic use; D015213:Neuroimmunomodulation / Q000276:immunology / Q000502:physiology; D012642:Selegiline / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D012642:Selegiline; D008911:Minocycline; D008559:Memantine
references.citation: Brain Res. 1995 Sep 18;692(1-2):278-82
references.pmid: 8548316
references.citation: Nat Med. 2006 Dec;12(12):1365-71
references.pmid: 17115046
references.citation: Med Sci Monit. 2007 Oct;13(10):SC1-3
references.pmid: 17901863
references.citation: J Infect Dis. 2001 Sep 15;184(6):699-706
references.pmid: 11517430
references.citation: J Chem Neuroanat. 2009 May;37(3):196-205
references.pmid: 19159677
references.citation: Brain. 2008 Dec;131(Pt 12):3311-34
references.pmid: 19015157
references.citation: J Neurosci. 1997 Sep 1;17(17):6669-77
references.pmid: 9254679
references.citation: Neurology. 2003 Jan 28;60(2):307-14
references.pmid: 12552050
references.citation: Exp Neurol. 2001 Nov;172(1):1-16
references.pmid: 11681836
references.citation: Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8075-80
references.pmid: 10869418
references.citation: Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19182-7
references.pmid: 17148615
references.citation: Physiol Rev. 2004 Jul;84(3):803-33
references.pmid: 15269337
references.citation: Nat Rev Immunol. 2005 Jan;5(1):69-81
references.pmid: 15630430
references.citation: Am J Physiol Cell Physiol. 2006 Feb;290(2):C345-51
references.pmid: 16403947
references.citation: Philos Trans R Soc Lond B Biol Sci. 2003 Apr 29;358(1432):667-74
references.pmid: 12740112
references.citation: Neuroreport. 2002 Jun 12;13(8):1067-70
references.pmid: 12060810
references.citation: Clin Pharmacokinet. 2001;40(12):907-46
references.pmid: 11735609
references.citation: Am J Pathol. 1997 Nov;151(5):1341-51
references.pmid: 9358760
references.citation: J Cell Sci. 2000 Jun;113 ( Pt 11):1851-6
references.pmid: 10806096
references.citation: J Virol. 1999 Oct;73(10):8720-31
references.pmid: 10482626
references.citation: Top HIV Med. 2008 Jun-Jul;16(2):94-8
references.pmid: 18591717
references.citation: J Acquir Immune Defic Syndr. 2002 Oct 1;31 Suppl 2:S84-8
references.pmid: 12394787
references.citation: J Neurosci. 2004 Aug 11;24(32):7194-8
references.pmid: 15306653
references.citation: Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3585-90
references.pmid: 17360686
references.citation: Mol Cell Neurosci. 2003 Sep;24(1):23-40
references.pmid: 14550766
references.citation: Can J Infect Dis Med Microbiol. 2005 Jul;16(4):230-2
references.pmid: 18159550
references.citation: Neurology. 2008 Feb 5;70(6):440-8
references.pmid: 17942819
references.citation: J Neurovirol. 2003 Apr;9(2):222-7
references.pmid: 12707852
references.citation: J Neuroimmunol. 2005 Nov;168(1-2):154-63
references.pmid: 16091292
references.citation: Annu Rev Neurosci. 2002;25:537-62
references.pmid: 12052920
references.citation: Curr Alzheimer Res. 2006 Feb;3(1):55-62
references.pmid: 16472204
references.citation: J Immunol. 1999 Aug 1;163(3):1636-46
references.pmid: 10415069
references.citation: Eur J Pharmacol. 2008 May 6;585(1):147-52
references.pmid: 18367167
references.citation: Eur J Neurosci. 2003 Jan;17(2):205-11
references.pmid: 12542656
references.citation: Nat Genet. 2003 Nov;35(3):238-45
references.pmid: 14517554
references.citation: Curr Opin Cell Biol. 1997 Aug;9(4):565-72
references.pmid: 9261059
references.citation: BMC Neurosci. 2008 Dec 10;9 Suppl 3:S5
references.pmid: 19091002
references.citation: Cell Death Differ. 2004 Jan;11(1):18-20
references.pmid: 14647237
references.citation: AIDS. 2007 Sep 12;21(14):1877-86
references.pmid: 17721095
references.citation: Lancet. 1997 Mar 8;349(9053):692-5
references.pmid: 9078201
references.citation: Nature. 1996 Aug 29;382(6594):767
references.pmid: 8752270
references.citation: J Neuroimmunol. 2001 Jul 2;117(1-2):97-107
references.pmid: 11431009
references.citation: J Immunol. 2001 Jun 15;166(12):7527-33
references.pmid: 11390507
references.citation: AIDS. 1993 May;7(5):669-75
references.pmid: 8318174
references.citation: Science. 1994 May 20;264(5162):1145-8
references.pmid: 8178174
references.citation: Ann Neurol. 2004 May;55(5):756
references.pmid: 15122721
references.citation: J Neurosci. 2000 Apr 15;20(8):2896-903
references.pmid: 10751442
references.citation: Curr Opin Pharmacol. 2007 Dec;7(6):633-7
references.pmid: 18023616
references.citation: Hippocampus. 2008;18(11):1085-8
references.pmid: 18651634
references.citation: Cell Death Differ. 2008 Oct;15(10):1663-72
references.pmid: 18583990
references.citation: Nature. 1992 Sep 24;359(6393):288-94
references.pmid: 1406932
references.citation: Nat Med. 2003 Jul;9(7):847-52
references.pmid: 12835704
references.citation: HIV Clin Trials. 2007 Nov-Dec;8(6):437-46
references.pmid: 18042509
references.citation: Science. 1990 Dec 14;250(4987):1593-6
references.pmid: 2148832
references.citation: Nat Med. 2000 Jul;6(7):797-801
references.pmid: 10888929
references.citation: J Neurosci. 2009 May 20;29(20):6734-51
references.pmid: 19458242
references.citation: J Neurochem. 2005 Jan;92(2):264-82
references.pmid: 15663475
references.citation: J Neurosci. 2006 Jan 18;26(3):981-90
references.pmid: 16421318
references.citation: Ann Neurol. 1986 Jun;19(6):517-24
references.pmid: 3729308
references.citation: Neurology. 2000 Feb 22;54(4):927-36
references.pmid: 10690988
references.citation: Exp Neurol. 2008 May;211(1):271-82
references.pmid: 18378231
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 5;791(1-2):337-43
references.pmid: 12798193
references.citation: Neurology. 2001 Aug 28;57(4):671-5
references.pmid: 11524477
references.citation: J Exp Med. 2003 Jun 16;197(12):1701-7
references.pmid: 12810688
references.citation: JAMA. 2004 Jan 21;291(3):317-24
references.pmid: 14734594
references.citation: Mol Psychiatry. 2009 Oct;14(10):959-67
references.pmid: 19255582
references.citation: J Comp Neurol. 1965 Jun;124(3):319-35
references.pmid: 5861717
references.citation: Growth Horm IGF Res. 2004 Jun;14 Suppl A:S39-43
references.pmid: 15135775
references.citation: Mol Pharmacol. 1997 Jul;52(1):6-15
references.pmid: 9224806
references.citation: PLoS One. 2008 Aug 13;3(8):e2935
references.pmid: 18698410
references.citation: Immunity. 2003 Jul;19(1):71-82
references.pmid: 12871640
references.citation: Expert Opin Ther Targets. 2005 Jun;9(3):571-9
references.pmid: 15948674
references.citation: J Neuroimmunol. 1999 Aug 3;98(2):185-200
references.pmid: 10430052
references.citation: J Physiol. 1997 Feb 15;499 ( Pt 1):27-46
references.pmid: 9061638
references.citation: Neuroscience. 2001;107(4):603-13
references.pmid: 11720784
references.citation: Diabetologia. 2000 Apr;43(4):500-6
references.pmid: 10819245
references.citation: PLoS Clin Trials. 2007 Mar 30;2(3):e13
references.pmid: 17401456
references.citation: Am J Pathol. 1997 Oct;151(4):1035-42
references.pmid: 9327737
references.citation: Neurobiol Aging. 2006 Mar;27(3):451-8
references.pmid: 15964100
references.citation: Virology. 1996 Dec 15;226(2):362-73
references.pmid: 8955056
references.citation: Neuromolecular Med. 2002;1(2):125-35
references.pmid: 12025858
references.citation: Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14669-74
references.pmid: 11724929
references.citation: Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):2074-7
references.pmid: 8446631
references.citation: Endocr Rev. 1996 Oct;17(5):518-32
references.pmid: 8897023
references.citation: PLoS One. 2008 Jun 25;3(6):e2516
references.pmid: 18575590
references.citation: Neuroscience. 2000;97(3):591-600
references.pmid: 10828541
references.citation: Curr Drug Targets. 2001 Sep;2(3):215-31
references.pmid: 11554549
references.citation: J Neurosci. 2002 Mar 15;22(6):2185-95
references.pmid: 11896158
references.citation: Neuroscience. 2004;127(2):481-96
references.pmid: 15262337
references.citation: Cell Death Differ. 2005 Aug;12 Suppl 1:878-92
references.pmid: 15832177
references.citation: J Neurovirol. 2002 Dec;8 Suppl 2:115-21
references.pmid: 12491162
references.citation: Neurosurgery. 2001 Jun;48(6):1393-9; discussion 1399-401
references.pmid: 11383749
references.citation: J Neurosci. 2001 Apr 15;21(8):2580-8
references.pmid: 11306611
references.citation: Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8212-6
references.pmid: 10393974
references.citation: Brain Res. 2003 Jul 25;979(1-2):65-70
references.pmid: 12850572
references.citation: Neuroscience. 2009 Jan 12;158(1):324-33
references.pmid: 18773944
references.citation: Physiol Behav. 1998 Jun 15;64(4):549-56
references.pmid: 9761231
references.citation: Trends Neurosci. 1999 Oct;22(10):471-9
references.pmid: 10481195
references.citation: N Engl J Med. 1992 Nov 5;327(19):1360-5
references.pmid: 1406838
references.citation: Ann Neurol. 1998 Nov;44(5):831-5
references.pmid: 9818943
references.citation: Neurology. 2009 Dec 8;73(23):1975-81
references.pmid: 19890073
references.citation: J Neurosci Res. 1997 Dec 15;50(6):990-9
references.pmid: 9452013
references.citation: Neurology. 2000 Jan 11;54(1):233-5
references.pmid: 10636157
references.citation: Annu Rev Biochem. 2007;76:823-47
references.pmid: 17243894
references.citation: J Neurosci. 1984 Jul;4(7):1884-91
references.pmid: 6737044
references.citation: Neurobiol Dis. 2008 Feb;29(2):316-26
references.pmid: 17980611
references.citation: Glia. 2001 Mar 1;33(3):181-90
references.pmid: 11241736
references.citation: Neuroscience. 2008 Mar 27;152(3):785-97
references.pmid: 18304744
references.citation: Science. 2000 Sep 22;289(5487):2122-5
references.pmid: 11000114
references.citation: Neurology. 2007 May 1;68(18):1481-7
references.pmid: 17470750
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Nov 15;827(1):65-75
references.pmid: 16183338
references.citation: J Virol. 2005 Aug;79(16):10830-4
references.pmid: 16051875
references.citation: Nat Rev Neurosci. 2007 May;8(5):368-78
references.pmid: 17453017
references.citation: J Virol. 2002 Jul;76(13):6689-700
references.pmid: 12050382
references.citation: Diabetes. 1999 Mar;48(3):557-63
references.pmid: 10078556
references.citation: Acta Otolaryngol. 2002 Jan;122(1):67-71
references.pmid: 11878282
references.citation: Am J Pathol. 2004 May;164(5):1557-66
references.pmid: 15111302
references.citation: J Immunol. 1997 Mar 15;158(6):2882-90
references.pmid: 9058825
references.citation: J Clin Endocrinol Metab. 2006 Feb;91(2):654-8
references.pmid: 16317062
references.citation: J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Mar 1;20(3):228-37
references.pmid: 10077170
references.citation: Physiol Behav. 1995 Aug;58(2):287-93
references.pmid: 7568432
references.citation: Neuron. 1999 Jul;23(3):583-92
references.pmid: 10433269
references.citation: Nat Neurosci. 2004 Jul;7(7):711-8
references.pmid: 15195093
references.citation: Nature. 2001 Apr 19;410(6831):988-94
references.pmid: 11309629
references.citation: J Neuroimmunol. 2001 Apr 2;115(1-2):168-75
references.pmid: 11282167
references.citation: Neuropathol Appl Neurobiol. 1993 Feb;19(1):3-9
references.pmid: 8474597
references.citation: J Neuroimmunol. 2004 Dec;157(1-2):3-10
references.pmid: 15579274
references.citation: Am J Pathol. 2004 Feb;164(2):355-62
references.pmid: 14742241
references.citation: Neurology. 2001 Aug 14;57(3):542-4
references.pmid: 11502933
references.citation: J Pharmacol Exp Ther. 2002 Mar;300(3):717-23
references.pmid: 11861773
references.citation: Neurology. 2006 Apr 25;66(8):1255-7
references.pmid: 16636247
references.citation: Physiol Behav. 1996 Apr-May;59(4-5):877-81
references.pmid: 8778881
references.citation: J Neurovirol. 2003 Apr;9(2):205-21
references.pmid: 12707851
references.citation: JAMA. 2005 Apr 27;293(16):2003-11
references.pmid: 15855434
references.citation: J Neuropathol Exp Neurol. 2003 Jun;62(6):617-26
references.pmid: 12834106
references.citation: Neurosci Biobehav Rev. 2008 Jul;32(5):883-909
references.pmid: 18430470
references.citation: J Neurosci. 2001 Mar 1;21(5):1628-34
references.pmid: 11222653
references.citation: Mol Pharmacol. 1997 Nov;52(5):821-8
references.pmid: 9351973
references.citation: Neurology. 2009 Dec 8;73(23):1982-7
references.pmid: 19907013
references.citation: Neurosci Lett. 2000 Jun 2;286(2):149-53
references.pmid: 10825658
references.citation: Eur J Neurosci. 2003 Aug;18(4):923-30
references.pmid: 12925018
references.citation: Ann Neurol. 1995 Nov;38(5):755-62
references.pmid: 7486867
references.citation: Acta Neurol Scand. 2008 Mar;117(3):205-10
references.pmid: 17854417
references.citation: Curr HIV Res. 2003 Oct;1(4):463-73
references.pmid: 15049431
references.citation: J Neurosci. 2002 Mar 1;22(5):1763-71
references.pmid: 11880505
references.citation: Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3112-7
references.pmid: 14981264
references.citation: J Neuroimmunol. 2004 Dec;157(1-2):111-9
references.pmid: 15579287
references.citation: Brain Res. 2009 Mar 3;1258:25-33
references.pmid: 19138677
references.citation: Science. 2000 Feb 25;287(5457):1433-8
references.pmid: 10688783
references.citation: Mol Cell Neurosci. 2002 Oct;21(2):312-23
references.pmid: 12401450
references.citation: J Comp Neurol. 1969 Jul;136(3):269-93
references.pmid: 5788129
references.citation: Am J Clin Nutr. 1998 Sep;68(3):720-5
references.pmid: 9734753
references.citation: Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14500-5
references.pmid: 9826729
references.citation: Nat Med. 1998 Nov;4(11):1313-7
references.pmid: 9809557
references.citation: Arch Neurol. 2007 Jan;64(1):97-102
references.pmid: 17210815
references.citation: J Immunol. 2009 Jul 1;183(1):661-9
references.pmid: 19535632
references.citation: J Virol. 2003 Jun;77(12):6899-912
references.pmid: 12768009
references.citation: Physiol Behav. 2004 Feb;80(5):669-74
references.pmid: 14984801
references.citation: Glia. 2009 Nov 1;57(14):1492-500
references.pmid: 19306367
references.citation: J Neuroimmune Pharmacol. 2007 Mar;2(1):81-6
references.pmid: 18040829
references.citation: Exp Neurol. 2007 Mar;204(1):77-87
references.pmid: 17070803
references.citation: Ann Neurol. 2003 Mar;53(3):405-9
references.pmid: 12601711
references.citation: Trends Endocrinol Metab. 2005 Mar;16(2):59-65
references.pmid: 15734146
references.citation: Curr HIV Res. 2005 Oct;3(4):303-17
references.pmid: 16250878
references.citation: Clin Exp Pharmacol Physiol. 1998 Jun;25(6):393-400
references.pmid: 9673812
references.citation: J Neurosci. 2007 Apr 4;27(14):3734-42
references.pmid: 17409237
references.citation: Ann Pharmacother. 2001 Mar;35(3):343-51
references.pmid: 11261533
references.citation: J Neuropathol Exp Neurol. 2002 Apr;61(4):358-67
references.pmid: 11939591
references.citation: J Alzheimers Dis. 2008 Apr;13(3):323-31
references.pmid: 18430999
references.citation: Eur J Neurosci. 2006 Feb;23(4):957-64
references.pmid: 16519660
references.citation: J Neuroimmunol. 2005 Sep;166(1-2):19-28
references.pmid: 16019082
references.citation: Annu Rev Neurosci. 2001;24:1-29
references.pmid: 11283303
references.citation: Neuroendocrinology. 2007;86(2):136-42
references.pmid: 17643054
references.citation: AIDS. 1999 Dec 24;13(18):2493-505
references.pmid: 10630518
references.citation: Antivir Ther. 2007;12(8):1175-83
references.pmid: 18240858
references.citation: J Pharmacol Exp Ther. 2006 Jan;316(1):106-12
references.pmid: 16162820
references.citation: Am J Physiol Endocrinol Metab. 2008 Mar;294(3):E558-67
references.pmid: 18171911
references.citation: Curr Opin Neurobiol. 2000 Apr;10(2):172-9
references.pmid: 10753798
references.citation: Neurology. 2007 Sep 25;69(13):1314-21
references.pmid: 17652642
references.citation: Neurology. 1992 Sep;42(9):1736-9
references.pmid: 1513462
references.citation: Psychoneuroendocrinology. 2004 Nov;29(10):1326-34
references.pmid: 15288712
references.citation: Eur J Neurosci. 2004 Dec;20(12):3222-32
references.pmid: 15610155
references.citation: Brain Res Dev Brain Res. 2002 Mar 31;134(1-2):115-22
references.pmid: 11947942
references.citation: Neurology. 2004 Dec 14;63(11):2084-90
references.pmid: 15596754
references.citation: Arch Clin Neuropsychol. 1997;12(6):557-65
references.pmid: 14590667
references.citation: J Comp Neurol. 2006 Mar 1;495(1):70-83
references.pmid: 16432899
references.citation: Ideggyogy Sz. 2007 Mar 30;60(3-4):144-7
references.pmid: 17451056
references.citation: J Infect Dis. 1987 Jul;156(1):189-93
references.pmid: 3474298
references.citation: CNS Neurol Disord Drug Targets. 2007 Oct;6(5):303-10
references.pmid: 18045158
references.citation: Med Sci Monit. 2009 Mar;15(3):LE1
references.pmid: 19247252
references.citation: Curr Neuropharmacol. 2008 Mar;6(1):55-78
references.pmid: 19305788
references.citation: J Neurovirol. 2008 Oct;14(5):376-88
references.pmid: 19003592
references.citation: J Neuroimmunol. 2004 Dec;157(1-2):176-84
references.pmid: 15579295
references.citation: Neurosci Lett. 2008 Jul 4;439(1):30-3
references.pmid: 18501511
references.citation: J Neuroimmunol. 2004 Jun;151(1-2):66-77
references.pmid: 15145605
references.citation: Science. 1988 Feb 5;239(4840):586-92
references.pmid: 3277272
references.citation: Ann Neurol. 2002 Jul;52(1):54-61
references.pmid: 12112047